Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease

With the introduction of more and more monoclonal antibodies selectively targeting various mediators of the immune system, together with Janus-Kinase (JAK)-inhibitors with variable affinities towards different JAK subtypes, the available therapeutic options for the treatment of inflammatory bowel di...

Descripción completa

Detalles Bibliográficos
Autores principales: Fries, Walter, Basile, Giorgio, Bellone, Federica, Costantino, Giuseppe, Viola, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340637/
https://www.ncbi.nlm.nih.gov/pubmed/37443755
http://dx.doi.org/10.3390/cells12131722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340637/
https://www.ncbi.nlm.nih.gov/pubmed/37443755
http://dx.doi.org/10.3390/cells12131722

Ejemplares similares